NYSEARCA:BOUT Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free BOUT Stock Alerts $33.41 -0.21 (-0.62%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$33.40▼$33.6450-Day Range$32.67▼$36.3352-Week Range$28.58▼$36.58Volume2,960 shsAverage Volume2,160 shsMarket Capitalization$13.36 millionAssets Under Management$13.47 millionDividend Yield1.20%Net Expense Ratio0.84% Stock AnalysisStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Get Innovator IBD Breakout Opportunities ETF alerts: Email Address About Innovator IBD Breakout Opportunities ETFThe Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.Read More BOUT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BOUT ETF News HeadlinesMarch 28, 2024 | msn.comWhy Cloud-Based Software Company Braze Shares Are Diving TodayMarch 9, 2024 | theglobeandmail.comA Look at China and the Emerging Market Equities SpaceApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!March 6, 2024 | msn.comNvidia, Palantir Surf Wave Of Breakouts, But Is The Tide Turning? Their Charts Say Not Yet.September 11, 2023 | finance.yahoo.comBOUT - Innovator IBD Breakout Opportunities ETFJuly 30, 2023 | morningstar.comInnovator ETFsJuly 25, 2023 | seekingalpha.comNUGO Nuveen Growth Opportunities ETFMay 10, 2023 | benzinga.comInnovator IBD Breakout Opportunities ETF (ARCA:BOUT), Quotes and News SummaryApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!March 22, 2023 | seekingalpha.comBOUT Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETFSee More Headlines Receive BOUT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerInnovator Capital Management Fund NameInnovator IBD Breakout Opportunities ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:BOUT Inception Date9/13/2018 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIBD Breakout Stocks Index CategoryBroad Equity FocusStrategy Development LevelDeveloped Markets RegionNorth America Number of Holdings26 Fund Statistics Assets Under Management$13.47 million Average Daily Volume$1,965.90 Discount/Premium-0.06% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorInnovator Capital Management, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bank, N.A. TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest300 shs Miscellaneous Outstanding Shares400,000Beta0.99 Creation Unit50,000 Creation Fee$250.00 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Innovator IBD Breakout Opportunities ETF ExpensesTypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.80%0.46%0.54%0.50%0.51%Other Expenses0.04%0.42%0.54%0.64%0.58%Total Expense0.84%0.61%0.70%0.74%0.70%Fee Waiver0.00%-0.44%-0.54%-0.68%-0.57%Net Expense0.84%0.51%0.60%0.57%0.58% Innovator IBD Breakout Opportunities ETF (BOUT) Holdings & ExposureTop 10 BOUT HoldingsWingstop(NASDAQ:WING)Holding Weight: 3.78%Northern Oil and Gas(NYSE:NOG)Holding Weight: 3.77%Texas Roadhouse(NASDAQ:TXRH)Holding Weight: 3.65%Morgan Stanley Direct Lending(NYSE:MSDL)Holding Weight: 3.64%TechnipFMC(NYSE:FTI)Holding Weight: 3.49%Turtle Beach(NASDAQ:HEAR)Holding Weight: 3.48%Lennar(NYSE:LEN)Holding Weight: 3.46%AZEK(NYSE:AZEK)Holding Weight: 3.43%BBB Foods(NYSE:TBBB)Holding Weight: 3.17%Xylem(NYSE:XYL)Holding Weight: 3.14%BOUT Sector ExposureBOUT Industry ExposureFull Holdings Details Similar ETFsMatthews Emerging Markets ex China Active ETFNYSEARCA:MEMXNuveen Dividend Growth ETFNYSEARCA:NDVGiShares USD Bond Factor ETFNASDAQ:USBFFlexShares Emerging Markets Quality Low Volatility Index FundNYSEARCA:QLVEGlobal X MSCI Vietnam ETFNYSEARCA:VNAM BOUT ETF - Frequently Asked Questions How have BOUT shares performed in 2024? Innovator IBD Breakout Opportunities ETF's stock was trading at $33.08 at the start of the year. Since then, BOUT shares have increased by 1.0% and is now trading at $33.4058. View the best growth stocks for 2024 here. What does BOUT invest in? Innovator IBD Breakout Opportunities ETF is a equity fund issued by Innovator Capital Management. BOUT focuses on strategy investments and follows the IBD Breakout Stocks Index. The fund's investments total to approximately $13.47 million assets under management. What stocks does Innovator IBD Breakout Opportunities ETF hold? BOUT invests in 26 holdings. Some of the stocks in their portfolio include Wingstop (WING), Northern Oil and Gas (NOG), Texas Roadhouse (TXRH), Morgan Stanley Direct Lending (MSDL), TechnipFMC (FTI), Turtle Beach (HEAR), Lennar (LEN), AZEK (AZEK), BBB Foods (TBBB) and Xylem (XYL). What is the management fee for Innovator IBD Breakout Opportunities ETF? Innovator IBD Breakout Opportunities ETF's management fee is 0.80% and has other expenses of 0.04%. The net expense ratio for BOUT is 0.84%. How do I buy shares of Innovator IBD Breakout Opportunities ETF? Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:BOUT) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD Breakout Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.